We confirmed that the KAT2A expression level was higher in C4-2-AbiR cells than in the parental C4-2 cell line and that KAT2A upregulation was correlated with a worse clinical survival outcome in patients with PC. Here, KAT2A is linked to pachyonychia congenita.